Waldencast PLC (NASDAQ:WALD – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $4.6667.
A number of research firms have recently commented on WALD. Telsey Advisory Group lowered shares of Waldencast from an “outperform” rating to a “market perform” rating and set a $3.00 price target for the company. in a research report on Tuesday, November 25th. Canaccord Genuity Group dropped their price objective on Waldencast from $5.00 to $4.00 and set a “buy” rating for the company in a research note on Tuesday, November 25th. Jefferies Financial Group restated a “buy” rating and set a $3.50 target price on shares of Waldencast in a research report on Tuesday, November 25th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Waldencast in a report on Wednesday, October 8th.
Get Our Latest Research Report on WALD
Institutional Investors Weigh In On Waldencast
Waldencast Price Performance
Shares of Waldencast stock opened at $1.99 on Friday. The company’s 50-day moving average price is $2.07 and its 200-day moving average price is $2.06. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 0.67. Waldencast has a 12-month low of $1.48 and a 12-month high of $4.10.
Waldencast (NASDAQ:WALD – Get Free Report) last issued its quarterly earnings data on Monday, November 24th. The company reported ($0.69) EPS for the quarter. The company had revenue of $66.14 million for the quarter. As a group, research analysts expect that Waldencast will post -0.14 earnings per share for the current year.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.
Further Reading
- Five stocks we like better than Waldencast
- Wall Street Stockpicker Names #1 Stock of 2026
- [URGENT!] SpaceX Going Public! – Pre-IPO Action
- ALERT: Drop these 5 stocks before January 2026!
- Shots officially fired…
- A month before the crash
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
